Mary Flack

2.1k citations
25 papers · 1.6k · 1 hit paper · h-index 11

Impact in

  • Immunology top 2%
    • Psoriasis: Treatment and Pathogenesis
    • Immunodeficiency and Autoimmune Disorders
  • Dermatology top 0.5%
    • Dermatology and Skin Diseases

Papers in

    • Psoriasis: Treatment and Pathogenesis 13
    • Acne and Rosacea Treatments and Effects 3
    • Dermatology and Skin Diseases 2

Mary Flack

22 papers receiving 1.6k citations

Mary Flack's Hit Papers

Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials 2018 · 470 citations
4700+2+5Years since publication100200300400

Peers

Mary Flack
Comparison fields: 5 of 66
  • Immunology 1.3k
  • Dermatology 515
  • Rheumatology 155
  • Hematology 100
  • Physiology 211
Replace H. Bachelez with:
H. Bachelez France
Isabelle Hampele United States
Gregory Kricorian United States
Marc Bourcier Canada
David Williams United States
Sophie Hugot Switzerland
J.M.P.A. van den Reek Netherlands
X. Bordas Spain
Martina Burlando Italy
Paolo Dapavo Italy
Mary Flack relative to H. Bachelez France H. Bachelez's profile →
Citations per field
00.5×10×20×29×
H. Bachelez · 1×
Citations per year

Countries citing papers authored by Mary Flack

Since Specialization
Citations

This map shows the geographic impact of Mary Flack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Flack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Flack more than expected).

Fields of papers citing papers by Mary Flack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Flack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Flack. The network helps show where Mary Flack may publish in the future.

Co-authors

The 25 scholars most cited alongside Mary Flack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mary Flack Line = papers co-authored together Mary Flack links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials
Hit paper breakdown →
2018470
2 2017401
3 2019222
4 2020147
5 201981
6 201860
7 201154
8 202151
9 200125
10 202215
11 200115
12
EFFICACY AND SAFETY OF RISANKIZUMAB: RESULTS FROM TWO DOUBLE-BLIND, PLACEBO- AND USTEKINUMAB-CONTROLLED, PHASE 3 TRIALS IN MODERATE-TO-SEVERE PLAQUE PSORIASIS
201810
13 20238
14 20218
15 20235
16 20204
17 20253
18
Subject-Assessed Time to Healing in a Randomized, Double-Blind, Vehicle-Controlled Trial of a Novel Topical Antiviral Nanoemulsion (NB-001) for Recurrent Herpes Labialis
20081
19 20011
20 20191

About Mary Flack

Mary Flack is a scholar working on Immunology, Dermatology, Pathology and Forensic Medicine, Epidemiology and Public Health, Environmental and Occupational Health, having authored 25 papers that have together received 1.6k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (13 papers), Systemic Sclerosis and Related Diseases (3 papers), Acne and Rosacea Treatments and Effects (3 papers), Dermatology and Skin Diseases (2 papers), Asthma and respiratory diseases (2 papers), Parasites and Host Interactions (1 paper), Trypanosoma species research and implications (1 paper) and Pharmacogenetics and Drug Metabolism (1 paper). The work is most often cited by research in Immunology (1.3k citations), Dermatology (515 citations), Rheumatology (155 citations), Hematology (100 citations) and Physiology (211 citations). Mary Flack has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Kim Papp, Andrew Blauvelt, Melinda Gooderham, Howard Sofen, Yihua Gu, Elizabeth H. Thompson, James G. Krueger, Ziqian Geng, Joaquin Valdes and Mamitaro Ohtsuki. Their work appears in journals such as Journal of the American Academy of Dermatology, Dermatology and Therapy, The Lancet, Journal of Scleroderma and Related Disorders and The Journal of Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact